

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 5.31529122 |
| 2 | fatty acid transmembrane transport (GO:1902001) | 5.30433829 |
| 3 | * regulation of sequestering of triglyceride (GO:0010889) | 5.12811296 |
| 4 | fatty acid beta-oxidation (GO:0006635) | 5.08550404 |
| 5 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.70661726 |
| 6 | tricarboxylic acid cycle (GO:0006099) | 4.69104220 |
| 7 | fatty acid catabolic process (GO:0009062) | 4.54865993 |
| 8 | fatty acid oxidation (GO:0019395) | 4.54735191 |
| 9 | lipid oxidation (GO:0034440) | 4.46660491 |
| 10 | biotin metabolic process (GO:0006768) | 4.44027358 |
| 11 | branched-chain amino acid catabolic process (GO:0009083) | 4.41894864 |
| 12 | valine metabolic process (GO:0006573) | 4.40678832 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.40249508 |
| 14 | lysine metabolic process (GO:0006553) | 4.38486960 |
| 15 | lysine catabolic process (GO:0006554) | 4.38486960 |
| 16 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.35548312 |
| 17 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.34950740 |
| 18 | 2-oxoglutarate metabolic process (GO:0006103) | 4.30749352 |
| 19 | acetyl-CoA metabolic process (GO:0006084) | 4.26825729 |
| 20 | positive regulation of fatty acid oxidation (GO:0046321) | 4.25834759 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.25351574 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 4.25351574 |
| 23 | regulation of cell communication by electrical coupling (GO:0010649) | 4.23265214 |
| 24 | detection of calcium ion (GO:0005513) | 4.22403335 |
| 25 | cardiac muscle contraction (GO:0060048) | 4.12307280 |
| 26 | carnitine transmembrane transport (GO:1902603) | 4.11022326 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.10155392 |
| 28 | L-phenylalanine metabolic process (GO:0006558) | 4.10155392 |
| 29 | branched-chain amino acid metabolic process (GO:0009081) | 4.08550200 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.06697186 |
| 31 | regulation of actin filament-based movement (GO:1903115) | 4.04224987 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.03951283 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.03454876 |
| 34 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.00721795 |
| 35 | monocarboxylic acid catabolic process (GO:0072329) | 4.00151089 |
| 36 | regulation of fatty acid oxidation (GO:0046320) | 3.99049449 |
| 37 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.98145852 |
| 38 | short-chain fatty acid metabolic process (GO:0046459) | 3.92577567 |
| 39 | low-density lipoprotein particle clearance (GO:0034383) | 3.88236912 |
| 40 | NADH metabolic process (GO:0006734) | 3.86816246 |
| 41 | carnitine transport (GO:0015879) | 3.86699409 |
| 42 | amino-acid betaine transport (GO:0015838) | 3.86699409 |
| 43 | cell communication involved in cardiac conduction (GO:0086065) | 3.85551633 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 3.83200807 |
| 45 | positive regulation of action potential (GO:0045760) | 3.82543117 |
| 46 | thioester biosynthetic process (GO:0035384) | 3.78935652 |
| 47 | acyl-CoA biosynthetic process (GO:0071616) | 3.78935652 |
| 48 | triglyceride catabolic process (GO:0019433) | 3.76733957 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.71030300 |
| 50 | aspartate family amino acid catabolic process (GO:0009068) | 3.70401774 |
| 51 | regulation of relaxation of muscle (GO:1901077) | 3.68000320 |
| 52 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.62770929 |
| 53 | neutral lipid catabolic process (GO:0046461) | 3.62082454 |
| 54 | acylglycerol catabolic process (GO:0046464) | 3.62082454 |
| 55 | carnitine metabolic process (GO:0009437) | 3.61874335 |
| 56 | regulation of membrane repolarization (GO:0060306) | 3.61081057 |
| 57 | fatty acid homeostasis (GO:0055089) | 3.60943787 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 3.60376907 |
| 59 | tricarboxylic acid metabolic process (GO:0072350) | 3.56988337 |
| 60 | succinate metabolic process (GO:0006105) | 3.48436698 |
| 61 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.47897060 |
| 62 | sarcomere organization (GO:0045214) | 3.46906871 |
| 63 | regulation of the force of heart contraction (GO:0002026) | 3.44783274 |
| 64 | positive regulation of lipid catabolic process (GO:0050996) | 3.43419305 |
| 65 | aromatic amino acid family catabolic process (GO:0009074) | 3.42032492 |
| 66 | glyoxylate metabolic process (GO:0046487) | 3.41856879 |
| 67 | oxaloacetate metabolic process (GO:0006107) | 3.41775445 |
| 68 | relaxation of cardiac muscle (GO:0055119) | 3.40900152 |
| 69 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.39919074 |
| 70 | adult heart development (GO:0007512) | 3.38601746 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 3.36645180 |
| 72 | regulation of heart rate (GO:0002027) | 3.35205883 |
| 73 | regulation of cofactor metabolic process (GO:0051193) | 3.33745326 |
| 74 | regulation of coenzyme metabolic process (GO:0051196) | 3.33745326 |
| 75 | response to pheromone (GO:0019236) | 3.33586984 |
| 76 | cardiac muscle cell action potential (GO:0086001) | 3.32513588 |
| 77 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.30521910 |
| 78 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.30417434 |
| 79 | ketone body metabolic process (GO:1902224) | 3.28707984 |
| 80 | regulation of striated muscle contraction (GO:0006942) | 3.28559335 |
| 81 | behavioral response to nicotine (GO:0035095) | 3.28228733 |
| 82 | cardiac muscle hypertrophy (GO:0003300) | 3.28056664 |
| 83 | positive regulation of heart rate (GO:0010460) | 3.27006925 |
| 84 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.25008654 |
| 85 | sulfur amino acid catabolic process (GO:0000098) | 3.23164351 |
| 86 | thioester metabolic process (GO:0035383) | 3.23009483 |
| 87 | acyl-CoA metabolic process (GO:0006637) | 3.23009483 |
| 88 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.22332862 |
| 89 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.21404097 |
| 90 | response to caffeine (GO:0031000) | 3.20066338 |
| 91 | adrenergic receptor signaling pathway (GO:0071875) | 3.19430725 |
| 92 | cell communication by electrical coupling (GO:0010644) | 3.18433097 |
| 93 | brown fat cell differentiation (GO:0050873) | 3.17362838 |
| 94 | organic acid catabolic process (GO:0016054) | 3.16977847 |
| 95 | carboxylic acid catabolic process (GO:0046395) | 3.16977847 |
| 96 | cardiac conduction (GO:0061337) | 3.16938224 |
| 97 | actomyosin structure organization (GO:0031032) | 3.16862175 |
| 98 | * triglyceride homeostasis (GO:0070328) | 3.14941217 |
| 99 | * acylglycerol homeostasis (GO:0055090) | 3.14941217 |
| 100 | regulation of action potential (GO:0098900) | 3.13293097 |
| 101 | complement activation, alternative pathway (GO:0006957) | 3.12886057 |
| 102 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.12463902 |
| 103 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.11899877 |
| 104 | regulation of cardiac muscle contraction (GO:0055117) | 3.11213371 |
| 105 | striated muscle hypertrophy (GO:0014897) | 3.10170968 |
| 106 | quaternary ammonium group transport (GO:0015697) | 3.08770629 |
| 107 | kynurenine metabolic process (GO:0070189) | 3.08748987 |
| 108 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.08077002 |
| 109 | striated muscle contraction (GO:0006941) | 3.07857392 |
| 110 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.06637814 |
| 111 | cardiac myofibril assembly (GO:0055003) | 3.05040394 |
| 112 | actin-mediated cell contraction (GO:0070252) | 3.04827544 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.04716426 |
| 114 | coenzyme catabolic process (GO:0009109) | 3.02177112 |
| 115 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.01942267 |
| 116 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.01492185 |
| 117 | positive regulation of sodium ion transport (GO:0010765) | 3.00934574 |
| 118 | intracellular lipid transport (GO:0032365) | 2.98804803 |
| 119 | bile acid biosynthetic process (GO:0006699) | 2.98295470 |
| 120 | positive regulation of glycolytic process (GO:0045821) | 2.96898012 |
| 121 | creatine metabolic process (GO:0006600) | 2.96191170 |
| 122 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.95828495 |
| 123 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.94863187 |
| 124 | coenzyme A metabolic process (GO:0015936) | 2.94473793 |
| 125 | negative regulation of lipase activity (GO:0060192) | 2.92714741 |
| 126 | alpha-amino acid catabolic process (GO:1901606) | 2.92246314 |
| 127 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.92126816 |
| 128 | myofibril assembly (GO:0030239) | 2.91317931 |
| 129 | ethanol oxidation (GO:0006069) | 2.91287127 |
| 130 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.90838683 |
| 131 | regulation of cholesterol metabolic process (GO:0090181) | 2.90502098 |
| 132 | cardiac muscle cell development (GO:0055013) | 2.90433067 |
| 133 | muscle filament sliding (GO:0030049) | 2.90094960 |
| 134 | actin-myosin filament sliding (GO:0033275) | 2.90094960 |
| 135 | triglyceride metabolic process (GO:0006641) | 2.88561870 |
| 136 | cellular amino acid catabolic process (GO:0009063) | 2.85940062 |
| 137 | triglyceride biosynthetic process (GO:0019432) | 2.84882653 |
| 138 | regulation of skeletal muscle contraction (GO:0014819) | 2.83844590 |
| 139 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.83546834 |
| 140 | muscle tissue morphogenesis (GO:0060415) | 2.83255039 |
| 141 | neutral lipid biosynthetic process (GO:0046460) | 2.81933363 |
| 142 | acylglycerol biosynthetic process (GO:0046463) | 2.81933363 |
| 143 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.81730978 |
| 144 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.80007242 |
| 145 | macroautophagy (GO:0016236) | 2.76360152 |
| 146 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.73939809 |
| 147 | action potential (GO:0001508) | 2.73811105 |
| 148 | response to inactivity (GO:0014854) | 2.73266254 |
| 149 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.73120738 |
| 150 | regulation of sarcomere organization (GO:0060297) | 2.69369988 |
| 151 | regulation of heart contraction (GO:0008016) | 2.68396720 |
| 152 | muscle hypertrophy (GO:0014896) | 2.63419904 |
| 153 | cardiac cell development (GO:0055006) | 2.63310400 |
| 154 | regulation of ATPase activity (GO:0043462) | 2.62187605 |
| 155 | regulation of ATP catabolic process (GO:1903289) | 2.62187605 |
| 156 | neuronal action potential (GO:0019228) | 2.59767860 |
| 157 | response to epinephrine (GO:0071871) | 2.56503978 |
| 158 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.55863422 |
| 159 | positive regulation of heart contraction (GO:0045823) | 2.54891557 |
| 160 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.52303174 |
| 161 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.50969627 |
| 162 | ubiquinone biosynthetic process (GO:0006744) | 2.50119891 |
| 163 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.49285593 |
| 164 | membrane depolarization during action potential (GO:0086010) | 2.48692866 |
| 165 | toxin metabolic process (GO:0009404) | 2.47346827 |
| 166 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.45015712 |
| 167 | ubiquinone metabolic process (GO:0006743) | 2.44371832 |
| 168 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.43733843 |
| 169 | endocardial cushion development (GO:0003197) | 2.38906810 |
| 170 | heart contraction (GO:0060047) | 2.38515487 |
| 171 | heart process (GO:0003015) | 2.38515487 |
| 172 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.37579663 |
| 173 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.37579663 |
| 174 | cAMP catabolic process (GO:0006198) | 2.37330669 |
| 175 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.36645163 |
| 176 | nephron tubule morphogenesis (GO:0072078) | 2.36423127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.61194307 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.75590557 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.98870115 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.30956878 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.24137444 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.21648611 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.58203361 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.57293567 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.22101872 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.87779923 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.81411454 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.59131114 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.57894424 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.42607806 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.39981880 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.30513173 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.28610159 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.17835051 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.12978833 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03907087 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.97004344 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.90114197 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79426198 |
| 24 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.77099220 |
| 25 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.77099220 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70102118 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68493005 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.62022177 |
| 29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61837364 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.58566391 |
| 31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.57714855 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.56369733 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53261361 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.51947333 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.51913088 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49633151 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49037225 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.48709238 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46071413 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44102892 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43578934 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43550426 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43305260 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42082921 |
| 45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.39944511 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39864928 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37697179 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36470114 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33036976 |
| 50 | TCF4_23295773_ChIP-Seq_U87_Human | 1.31267122 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31236039 |
| 52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30364860 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30240363 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29951839 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29422477 |
| 56 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28379746 |
| 57 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.28335242 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27207282 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26344504 |
| 60 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25630309 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24009454 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23727295 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22343555 |
| 64 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21295107 |
| 65 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20926059 |
| 66 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20755251 |
| 67 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.20713476 |
| 68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19541704 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19540147 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18383840 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17428525 |
| 72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16444927 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14299773 |
| 74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.13902663 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13036418 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12455356 |
| 77 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.12152474 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11517266 |
| 79 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11152845 |
| 80 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09396710 |
| 81 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08829041 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08381577 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08109187 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08109187 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06983936 |
| 86 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06921769 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06377958 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04747282 |
| 89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02453540 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02292036 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01867387 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01819565 |
| 93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98557026 |
| 94 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97051677 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96459442 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96050695 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95818970 |
| 98 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95607208 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95603492 |
| 100 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.94948527 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94113265 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94080173 |
| 103 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92737095 |
| 104 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91904531 |
| 105 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91272305 |
| 106 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91238302 |
| 107 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91217843 |
| 108 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.90605412 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89926986 |
| 110 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89913479 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87713715 |
| 112 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.85348301 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85235730 |
| 114 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82075353 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81978849 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81040071 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77088630 |
| 118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76269398 |
| 119 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.75891074 |
| 120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.75599668 |
| 121 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75563439 |
| 122 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.75542577 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75104990 |
| 124 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.74609583 |
| 125 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.74586214 |
| 126 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73182825 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.72302411 |
| 128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72102754 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71675386 |
| 130 | CJUN_26792858_Chip-Seq_BT549_Human | 0.71640802 |
| 131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71350495 |
| 132 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71156134 |
| 133 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.70424430 |
| 134 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.68226664 |
| 135 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.66870134 |
| 136 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65668637 |
| 137 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.64632565 |
| 138 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.63458289 |
| 139 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.63456934 |
| 140 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.63003447 |
| 141 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.62839286 |
| 142 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.61951812 |
| 143 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.61149600 |
| 144 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.61149600 |
| 145 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60970652 |
| 146 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60940195 |
| 147 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.59569998 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.59507885 |
| 149 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.59357999 |
| 150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58993164 |
| 151 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.58586304 |
| 152 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57549977 |
| 153 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.57236687 |
| 154 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.57073730 |
| 155 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.56926045 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55772568 |
| 157 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.55743151 |
| 158 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.54986963 |
| 159 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54978945 |
| 160 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54757870 |
| 161 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53944458 |
| 162 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53763762 |
| 163 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.52831277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.35771013 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.13477581 |
| 3 | MP0005670_abnormal_white_adipose | 3.98341713 |
| 4 | MP0004130_abnormal_muscle_cell | 3.57759100 |
| 5 | MP0005365_abnormal_bile_salt | 3.50410237 |
| 6 | MP0003646_muscle_fatigue | 3.45794464 |
| 7 | MP0005360_urolithiasis | 3.28520398 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.21944021 |
| 9 | MP0005666_abnormal_adipose_tissue | 2.98091236 |
| 10 | MP0000751_myopathy | 2.91634942 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.56092792 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.52968013 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.51809428 |
| 14 | MP0000749_muscle_degeneration | 2.39713233 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.39468316 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.38356210 |
| 17 | MP0005330_cardiomyopathy | 2.32283145 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 2.26580724 |
| 19 | MP0005375_adipose_tissue_phenotype | 2.14507128 |
| 20 | MP0003195_calcinosis | 2.06968780 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.05310643 |
| 22 | MP0003252_abnormal_bile_duct | 2.04330460 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.00242691 |
| 24 | MP0002971_abnormal_brown_adipose | 1.90611554 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.88705542 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.88651850 |
| 27 | MP0004087_abnormal_muscle_fiber | 1.86693814 |
| 28 | MP0002972_abnormal_cardiac_muscle | 1.76890899 |
| 29 | MP0005620_abnormal_muscle_contractility | 1.76846723 |
| 30 | MP0003122_maternal_imprinting | 1.76709358 |
| 31 | MP0005332_abnormal_amino_acid | 1.75811142 |
| 32 | MP0005083_abnormal_biliary_tract | 1.71373362 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.64623382 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.61765006 |
| 35 | MP0002269_muscular_atrophy | 1.58664471 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.58648813 |
| 37 | MP0009046_muscle_twitch | 1.53977098 |
| 38 | MP0000003_abnormal_adipose_tissue | 1.53376381 |
| 39 | MP0005385_cardiovascular_system_phenoty | 1.52856619 |
| 40 | MP0001544_abnormal_cardiovascular_syste | 1.52856619 |
| 41 | MP0006138_congestive_heart_failure | 1.52817405 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.48694994 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.45925736 |
| 44 | MP0009840_abnormal_foam_cell | 1.45479178 |
| 45 | MP0002078_abnormal_glucose_homeostasis | 1.45270027 |
| 46 | MP0005535_abnormal_body_temperature | 1.44633024 |
| 47 | MP0005334_abnormal_fat_pad | 1.43532232 |
| 48 | MP0003137_abnormal_impulse_conducting | 1.43145406 |
| 49 | MP0000747_muscle_weakness | 1.41675295 |
| 50 | MP0000609_abnormal_liver_physiology | 1.41605954 |
| 51 | MP0004510_myositis | 1.40040357 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.39830415 |
| 53 | MP0002106_abnormal_muscle_physiology | 1.38252880 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.35300338 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.34660816 |
| 56 | MP0009745_abnormal_behavioral_response | 1.32202223 |
| 57 | MP0004043_abnormal_pH_regulation | 1.31975675 |
| 58 | MP0010630_abnormal_cardiac_muscle | 1.29153311 |
| 59 | MP0005319_abnormal_enzyme/_coenzyme | 1.28585498 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.27863134 |
| 61 | MP0003136_yellow_coat_color | 1.26534130 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.25832154 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.24347174 |
| 64 | MP0004924_abnormal_behavior | 1.24347174 |
| 65 | MP0002272_abnormal_nervous_system | 1.24267713 |
| 66 | MP0004484_altered_response_of | 1.22131391 |
| 67 | MP0001666_abnormal_nutrient_absorption | 1.21948765 |
| 68 | MP0001984_abnormal_olfaction | 1.20504050 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.20338459 |
| 70 | MP0004885_abnormal_endolymph | 1.20243203 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18558788 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.18304058 |
| 73 | MP0005369_muscle_phenotype | 1.17751769 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16121504 |
| 75 | MP0005187_abnormal_penis_morphology | 1.15924770 |
| 76 | MP0001661_extended_life_span | 1.10862261 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 1.10162368 |
| 78 | MP0004085_abnormal_heartbeat | 1.07868177 |
| 79 | MP0009115_abnormal_fat_cell | 1.05027440 |
| 80 | MP0003283_abnormal_digestive_organ | 1.04458820 |
| 81 | MP0005451_abnormal_body_composition | 1.04286034 |
| 82 | MP0002064_seizures | 1.03526216 |
| 83 | MP0005275_abnormal_skin_tensile | 0.99071148 |
| 84 | MP0005448_abnormal_energy_balance | 0.99030826 |
| 85 | MP0000230_abnormal_systemic_arterial | 0.98172914 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.97378020 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.97300982 |
| 88 | MP0001529_abnormal_vocalization | 0.95537675 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.94376168 |
| 90 | MP0001486_abnormal_startle_reflex | 0.93501730 |
| 91 | MP0004142_abnormal_muscle_tone | 0.93234993 |
| 92 | MP0002970_abnormal_white_adipose | 0.92060717 |
| 93 | MP0000427_abnormal_hair_cycle | 0.91752830 |
| 94 | MP0001968_abnormal_touch/_nociception | 0.91286028 |
| 95 | MP0001764_abnormal_homeostasis | 0.90059998 |
| 96 | MP0003121_genomic_imprinting | 0.88326558 |
| 97 | MP0002572_abnormal_emotion/affect_behav | 0.88257814 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.87021507 |
| 99 | MP0003959_abnormal_lean_body | 0.86915964 |
| 100 | MP0003186_abnormal_redox_activity | 0.86253871 |
| 101 | MP0004233_abnormal_muscle_weight | 0.85811328 |
| 102 | MP0006276_abnormal_autonomic_nervous | 0.83596337 |
| 103 | MP0005423_abnormal_somatic_nervous | 0.82569220 |
| 104 | MP0001502_abnormal_circadian_rhythm | 0.81694199 |
| 105 | MP0005266_abnormal_metabolism | 0.81083750 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.80658759 |
| 107 | MP0003828_pulmonary_edema | 0.80568852 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.78274406 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.77867891 |
| 110 | MP0002108_abnormal_muscle_morphology | 0.77075507 |
| 111 | MP0003635_abnormal_synaptic_transmissio | 0.76392936 |
| 112 | MP0002063_abnormal_learning/memory/cond | 0.75459450 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.74861686 |
| 114 | MP0004019_abnormal_vitamin_homeostasis | 0.74699913 |
| 115 | MP0005452_abnormal_adipose_tissue | 0.74477252 |
| 116 | MP0001501_abnormal_sleep_pattern | 0.73782773 |
| 117 | MP0003953_abnormal_hormone_level | 0.73389459 |
| 118 | MP0009384_cardiac_valve_regurgitation | 0.73252583 |
| 119 | MP0004133_heterotaxia | 0.72874346 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.72567533 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.72280629 |
| 122 | MP0005645_abnormal_hypothalamus_physiol | 0.71962553 |
| 123 | MP0005253_abnormal_eye_physiology | 0.71941668 |
| 124 | MP0001970_abnormal_pain_threshold | 0.69460772 |
| 125 | MP0002938_white_spotting | 0.69340196 |
| 126 | MP0000372_irregular_coat_pigmentation | 0.68648837 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.67310532 |
| 128 | MP0003690_abnormal_glial_cell | 0.66491823 |
| 129 | MP0003329_amyloid_beta_deposits | 0.66425035 |
| 130 | MP0003787_abnormal_imprinting | 0.65634564 |
| 131 | MP0002067_abnormal_sensory_capabilities | 0.65546089 |
| 132 | MP0002160_abnormal_reproductive_system | 0.64460126 |
| 133 | MP0002138_abnormal_hepatobiliary_system | 0.64202749 |
| 134 | MP0002127_abnormal_cardiovascular_syste | 0.63958671 |
| 135 | MP0001756_abnormal_urination | 0.63943738 |
| 136 | MP0003567_abnormal_fetal_cardiomyocyte | 0.63140616 |
| 137 | MP0003868_abnormal_feces_composition | 0.60529267 |
| 138 | MP0004147_increased_porphyrin_level | 0.60322239 |
| 139 | MP0000343_altered_response_to | 0.60133256 |
| 140 | MP0009642_abnormal_blood_homeostasis | 0.57047092 |
| 141 | MP0005165_increased_susceptibility_to | 0.55494941 |
| 142 | MP0003011_delayed_dark_adaptation | 0.54761826 |
| 143 | MP0009697_abnormal_copulation | 0.54303180 |
| 144 | MP0001944_abnormal_pancreas_morphology | 0.54095941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.99023475 |
| 2 | Myoglobinuria (HP:0002913) | 4.96540198 |
| 3 | Ketoacidosis (HP:0001993) | 4.64180717 |
| 4 | Exercise-induced myalgia (HP:0003738) | 4.41448425 |
| 5 | Ketosis (HP:0001946) | 4.38255437 |
| 6 | Hyperglycinuria (HP:0003108) | 4.25057991 |
| 7 | Sudden death (HP:0001699) | 4.21982129 |
| 8 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.14323183 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.79206792 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 3.79206792 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 3.76736938 |
| 12 | Rhabdomyolysis (HP:0003201) | 3.70101172 |
| 13 | Ventricular fibrillation (HP:0001663) | 3.69980071 |
| 14 | Hyperammonemia (HP:0001987) | 3.66231234 |
| 15 | Exercise-induced muscle cramps (HP:0003710) | 3.65064342 |
| 16 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.63485829 |
| 17 | Ventricular tachycardia (HP:0004756) | 3.59889372 |
| 18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.59631123 |
| 19 | Dicarboxylic aciduria (HP:0003215) | 3.59631123 |
| 20 | Xanthomatosis (HP:0000991) | 3.59423719 |
| 21 | Left ventricular hypertrophy (HP:0001712) | 3.58648948 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.53806943 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 3.48444825 |
| 24 | Muscle fiber splitting (HP:0003555) | 3.46534903 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.39954315 |
| 26 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.32926471 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.32859037 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 3.32053913 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.26473452 |
| 30 | Intrahepatic cholestasis (HP:0001406) | 3.16525332 |
| 31 | Palpitations (HP:0001962) | 3.13120422 |
| 32 | Lipoatrophy (HP:0100578) | 3.09769568 |
| 33 | Hepatic necrosis (HP:0002605) | 3.08035509 |
| 34 | Hyperglycinemia (HP:0002154) | 3.07736297 |
| 35 | Increased connective tissue (HP:0009025) | 3.03340330 |
| 36 | Oligomenorrhea (HP:0000876) | 2.99903519 |
| 37 | Difficulty running (HP:0009046) | 2.99013176 |
| 38 | Cerebral edema (HP:0002181) | 2.98778091 |
| 39 | Deep venous thrombosis (HP:0002625) | 2.94506467 |
| 40 | Epidermoid cyst (HP:0200040) | 2.94269700 |
| 41 | Atrial fibrillation (HP:0005110) | 2.92923278 |
| 42 | Hyperglycemia (HP:0003074) | 2.86584325 |
| 43 | Generalized aminoaciduria (HP:0002909) | 2.86544145 |
| 44 | Skin nodule (HP:0200036) | 2.85973825 |
| 45 | Abnormal EKG (HP:0003115) | 2.84891714 |
| 46 | Type II lissencephaly (HP:0007260) | 2.82954041 |
| 47 | Abnormality of the calf musculature (HP:0001430) | 2.82920117 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.82648076 |
| 49 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.82393863 |
| 50 | Large for gestational age (HP:0001520) | 2.80194282 |
| 51 | Hypolipoproteinemia (HP:0010981) | 2.80134041 |
| 52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.75484491 |
| 53 | Hyperventilation (HP:0002883) | 2.74346659 |
| 54 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.73195104 |
| 55 | Abnormality of alanine metabolism (HP:0010916) | 2.73195104 |
| 56 | Hyperalaninemia (HP:0003348) | 2.73195104 |
| 57 | Dilated cardiomyopathy (HP:0001644) | 2.72896746 |
| 58 | Increased muscle lipid content (HP:0009058) | 2.70380411 |
| 59 | Primary atrial arrhythmia (HP:0001692) | 2.67758020 |
| 60 | Complement deficiency (HP:0004431) | 2.64826206 |
| 61 | Abnormality of the renal cortex (HP:0011035) | 2.61484618 |
| 62 | Syncope (HP:0001279) | 2.58481417 |
| 63 | Metabolic acidosis (HP:0001942) | 2.58450449 |
| 64 | Arthropathy (HP:0003040) | 2.58285853 |
| 65 | Acute encephalopathy (HP:0006846) | 2.56864078 |
| 66 | Bundle branch block (HP:0011710) | 2.54710907 |
| 67 | Prolonged partial thromboplastin time (HP:0003645) | 2.54638028 |
| 68 | Muscle stiffness (HP:0003552) | 2.53523114 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.53156848 |
| 70 | Supraventricular tachycardia (HP:0004755) | 2.52875241 |
| 71 | Lethargy (HP:0001254) | 2.49195208 |
| 72 | Supraventricular arrhythmia (HP:0005115) | 2.49011740 |
| 73 | EMG: neuropathic changes (HP:0003445) | 2.48068868 |
| 74 | EMG: myopathic abnormalities (HP:0003458) | 2.43326374 |
| 75 | Atrioventricular block (HP:0001678) | 2.42335237 |
| 76 | Prominent supraorbital ridges (HP:0000336) | 2.36985364 |
| 77 | Heart block (HP:0012722) | 2.35849748 |
| 78 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.32945322 |
| 79 | Myotonia (HP:0002486) | 2.31421075 |
| 80 | Pheochromocytoma (HP:0002666) | 2.28646719 |
| 81 | Hypobetalipoproteinemia (HP:0003563) | 2.28572972 |
| 82 | Pancreatic cysts (HP:0001737) | 2.27849215 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.25789434 |
| 84 | Cholelithiasis (HP:0001081) | 2.25610536 |
| 85 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.25514710 |
| 86 | Abnormal atrioventricular conduction (HP:0005150) | 2.24874039 |
| 87 | Ventricular arrhythmia (HP:0004308) | 2.24174998 |
| 88 | Abnormality of serum amino acid levels (HP:0003112) | 2.24089582 |
| 89 | Renal cortical cysts (HP:0000803) | 2.23242932 |
| 90 | Subaortic stenosis (HP:0001682) | 2.22910940 |
| 91 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.22910940 |
| 92 | Acute necrotizing encephalopathy (HP:0006965) | 2.20593384 |
| 93 | Acanthosis nigricans (HP:0000956) | 2.19902225 |
| 94 | Hepatocellular necrosis (HP:0001404) | 2.19257217 |
| 95 | Prolonged QT interval (HP:0001657) | 2.19191204 |
| 96 | Vomiting (HP:0002013) | 2.17300218 |
| 97 | Late onset (HP:0003584) | 2.16337007 |
| 98 | Conjunctival hamartoma (HP:0100780) | 2.16053585 |
| 99 | Tubular atrophy (HP:0000092) | 2.15731796 |
| 100 | Type 1 muscle fiber predominance (HP:0003803) | 2.14541513 |
| 101 | Proximal tubulopathy (HP:0000114) | 2.12275464 |
| 102 | Hypertriglyceridemia (HP:0002155) | 2.10113737 |
| 103 | Abnormality of purine metabolism (HP:0004352) | 2.10033826 |
| 104 | Lactic acidosis (HP:0003128) | 2.10013133 |
| 105 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09538104 |
| 106 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.08840096 |
| 107 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08243620 |
| 108 | Abnormality of glycolysis (HP:0004366) | 2.05644570 |
| 109 | Increased serum pyruvate (HP:0003542) | 2.05644570 |
| 110 | Nephronophthisis (HP:0000090) | 2.02886198 |
| 111 | Gout (HP:0001997) | 2.02302491 |
| 112 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.01299616 |
| 113 | Nausea (HP:0002018) | 2.00751843 |
| 114 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.00313006 |
| 115 | Symptomatic seizures (HP:0011145) | 1.99276826 |
| 116 | Frequent falls (HP:0002359) | 1.98930008 |
| 117 | Insulin resistance (HP:0000855) | 1.97802395 |
| 118 | Distal lower limb muscle weakness (HP:0009053) | 1.95147411 |
| 119 | Bradycardia (HP:0001662) | 1.94584465 |
| 120 | Pancreatic fibrosis (HP:0100732) | 1.93383426 |
| 121 | Pachygyria (HP:0001302) | 1.92855259 |
| 122 | True hermaphroditism (HP:0010459) | 1.92371034 |
| 123 | Abnormality of the renal medulla (HP:0100957) | 1.92297409 |
| 124 | Muscular dystrophy (HP:0003560) | 1.92255737 |
| 125 | Decreased circulating renin level (HP:0003351) | 1.88471774 |
| 126 | Congenital stationary night blindness (HP:0007642) | 1.86922517 |
| 127 | Concave nail (HP:0001598) | 1.85556047 |
| 128 | Rimmed vacuoles (HP:0003805) | 1.84666739 |
| 129 | Abnormality of midbrain morphology (HP:0002418) | 1.79031978 |
| 130 | Molar tooth sign on MRI (HP:0002419) | 1.79031978 |
| 131 | Severe muscular hypotonia (HP:0006829) | 1.77310845 |
| 132 | Medial flaring of the eyebrow (HP:0010747) | 1.75993655 |
| 133 | Cerebellar dysplasia (HP:0007033) | 1.75787850 |
| 134 | Abnormal drinking behavior (HP:0030082) | 1.75754487 |
| 135 | Polydipsia (HP:0001959) | 1.75754487 |
| 136 | Broad-based gait (HP:0002136) | 1.72759947 |
| 137 | Focal seizures (HP:0007359) | 1.68483999 |
| 138 | Sudden cardiac death (HP:0001645) | 1.63765494 |
| 139 | Generalized muscle weakness (HP:0003324) | 1.63658836 |
| 140 | Congenital, generalized hypertrichosis (HP:0004540) | 1.62089153 |
| 141 | Palmoplantar keratoderma (HP:0000982) | 1.61765987 |
| 142 | Progressive cerebellar ataxia (HP:0002073) | 1.60791066 |
| 143 | Areflexia of lower limbs (HP:0002522) | 1.59525224 |
| 144 | Infantile muscular hypotonia (HP:0008947) | 1.59130271 |
| 145 | Cystic liver disease (HP:0006706) | 1.59074103 |
| 146 | Gaze-evoked nystagmus (HP:0000640) | 1.57354866 |
| 147 | Lissencephaly (HP:0001339) | 1.56996166 |
| 148 | Anxiety (HP:0000739) | 1.56943269 |
| 149 | Inability to walk (HP:0002540) | 1.56912973 |
| 150 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.56668013 |
| 151 | Gait imbalance (HP:0002141) | 1.56619444 |
| 152 | Hemiparesis (HP:0001269) | 1.56298284 |
| 153 | Testicular atrophy (HP:0000029) | 1.55541943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.28110449 |
| 2 | TTN | 3.48570606 |
| 3 | INSRR | 3.36667890 |
| 4 | PDK4 | 3.33964738 |
| 5 | PDK3 | 3.33964738 |
| 6 | TRIB3 | 3.14923980 |
| 7 | OBSCN | 3.13947977 |
| 8 | PHKG1 | 3.11106347 |
| 9 | PHKG2 | 3.11106347 |
| 10 | LMTK2 | 3.05687541 |
| 11 | MARK1 | 2.64110235 |
| 12 | SIK1 | 2.54458429 |
| 13 | PINK1 | 2.25244559 |
| 14 | ADRBK2 | 2.18829368 |
| 15 | BMPR1B | 2.02904635 |
| 16 | CAMK1D | 1.98005333 |
| 17 | PKN2 | 1.96487520 |
| 18 | PDK2 | 1.93644118 |
| 19 | CASK | 1.85761789 |
| 20 | MAP4K2 | 1.83488382 |
| 21 | MYLK | 1.80084306 |
| 22 | PIK3CA | 1.79155099 |
| 23 | ERN1 | 1.77635578 |
| 24 | LIMK1 | 1.75806184 |
| 25 | TIE1 | 1.54582060 |
| 26 | PRKAA2 | 1.44443109 |
| 27 | WNK4 | 1.42786047 |
| 28 | CAMK1G | 1.42775912 |
| 29 | ACVR1B | 1.42641614 |
| 30 | NTRK3 | 1.38085311 |
| 31 | FGFR4 | 1.30301285 |
| 32 | GRK1 | 1.29566926 |
| 33 | RIPK1 | 1.23603936 |
| 34 | MUSK | 1.21077478 |
| 35 | MAPK13 | 1.20619098 |
| 36 | PAK3 | 1.17477480 |
| 37 | MAP2K4 | 1.15260268 |
| 38 | PRKAA1 | 1.14732064 |
| 39 | FLT3 | 1.14521985 |
| 40 | ADRBK1 | 1.12061625 |
| 41 | PIK3CG | 1.11566401 |
| 42 | DMPK | 1.07602423 |
| 43 | FGFR2 | 1.07097251 |
| 44 | NTRK2 | 1.02034549 |
| 45 | CAMKK2 | 0.98510642 |
| 46 | AKT3 | 0.93732987 |
| 47 | FRK | 0.92747318 |
| 48 | PRKD1 | 0.91183023 |
| 49 | MST1R | 0.89602800 |
| 50 | CAMK2D | 0.88338897 |
| 51 | MAP3K7 | 0.88318887 |
| 52 | PNCK | 0.86348377 |
| 53 | NEK9 | 0.86106448 |
| 54 | PDGFRA | 0.83464309 |
| 55 | GRK7 | 0.82866517 |
| 56 | MAPK12 | 0.82463901 |
| 57 | LATS1 | 0.81862753 |
| 58 | MAP2K6 | 0.77116662 |
| 59 | STK38L | 0.76633636 |
| 60 | PRKD3 | 0.75930750 |
| 61 | NEK1 | 0.74566331 |
| 62 | MAP2K1 | 0.74206755 |
| 63 | PDPK1 | 0.73280233 |
| 64 | PRKACG | 0.72796258 |
| 65 | PRKCG | 0.72523841 |
| 66 | WNK3 | 0.71219601 |
| 67 | EPHB1 | 0.70291871 |
| 68 | MAP2K2 | 0.69980532 |
| 69 | MAP2K3 | 0.69601471 |
| 70 | WNK1 | 0.64449989 |
| 71 | STK11 | 0.64337976 |
| 72 | TLK1 | 0.64280386 |
| 73 | FER | 0.64119211 |
| 74 | CAMK2B | 0.62663554 |
| 75 | MAP3K3 | 0.62274809 |
| 76 | TAOK3 | 0.62138561 |
| 77 | STK39 | 0.62002592 |
| 78 | OXSR1 | 0.61692501 |
| 79 | PRKCH | 0.61429949 |
| 80 | RET | 0.61294086 |
| 81 | PKN1 | 0.60922234 |
| 82 | MET | 0.60781252 |
| 83 | ERBB4 | 0.59966917 |
| 84 | CDC42BPA | 0.55488625 |
| 85 | TYRO3 | 0.54580592 |
| 86 | MAPK11 | 0.54444939 |
| 87 | CAMK2G | 0.53424989 |
| 88 | EPHA2 | 0.52284625 |
| 89 | PRKCE | 0.51711294 |
| 90 | PRKACA | 0.50650304 |
| 91 | ZAK | 0.50393964 |
| 92 | SGK3 | 0.50166492 |
| 93 | ROCK1 | 0.48638815 |
| 94 | PRKG1 | 0.48551468 |
| 95 | DYRK2 | 0.48089813 |
| 96 | DAPK2 | 0.47994403 |
| 97 | JAK1 | 0.47473231 |
| 98 | TGFBR1 | 0.47380119 |
| 99 | RPS6KA6 | 0.46840747 |
| 100 | PDK1 | 0.46557700 |
| 101 | MAP3K5 | 0.46101668 |
| 102 | MAP2K7 | 0.45329096 |
| 103 | JAK2 | 0.44756753 |
| 104 | FGFR3 | 0.44675349 |
| 105 | SGK223 | 0.44338937 |
| 106 | SGK494 | 0.44338937 |
| 107 | EPHB2 | 0.44245973 |
| 108 | CAMK2A | 0.43874596 |
| 109 | EPHA3 | 0.43091355 |
| 110 | MAP3K6 | 0.42614563 |
| 111 | TRPM7 | 0.41794615 |
| 112 | STK24 | 0.41358773 |
| 113 | MAPK15 | 0.41134889 |
| 114 | MAP3K4 | 0.40464144 |
| 115 | IRAK1 | 0.40367119 |
| 116 | PTK6 | 0.40340889 |
| 117 | ABL2 | 0.38896342 |
| 118 | EPHA4 | 0.38537484 |
| 119 | NLK | 0.37887702 |
| 120 | CAMK1 | 0.37670822 |
| 121 | SGK2 | 0.36914131 |
| 122 | MAPKAPK3 | 0.36310766 |
| 123 | RPS6KA3 | 0.36183695 |
| 124 | CAMK4 | 0.35804577 |
| 125 | MAP3K1 | 0.35776931 |
| 126 | PTK2B | 0.35419101 |
| 127 | ROCK2 | 0.35030032 |
| 128 | GSK3A | 0.34699904 |
| 129 | PAK6 | 0.33894226 |
| 130 | NTRK1 | 0.33618906 |
| 131 | TNIK | 0.33455814 |
| 132 | PRKACB | 0.33224171 |
| 133 | PLK2 | 0.33190373 |
| 134 | LATS2 | 0.32474504 |
| 135 | IRAK2 | 0.32209546 |
| 136 | MAP3K2 | 0.32188497 |
| 137 | STK38 | 0.30771251 |
| 138 | FES | 0.30632129 |
| 139 | PRKCZ | 0.30192463 |
| 140 | PRKCA | 0.28931641 |
| 141 | NUAK1 | 0.28251160 |
| 142 | CDK5 | 0.26213098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.70231351 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.69319168 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.45870056 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.43217283 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.02791550 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.02259403 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61631383 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.58018464 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46679004 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.39391103 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36029139 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24200150 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18113995 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.13496414 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.09940053 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.96782430 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96321439 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.91099676 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85663978 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83263731 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82921959 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.78417563 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47869578 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47421594 |
| 25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46576790 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38227711 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36744521 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31801443 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27520307 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22582806 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19689311 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19626774 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17879224 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17570405 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.16614300 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15619756 |
| 37 | GABAergic synapse_Homo sapiens_hsa04727 | 1.14446521 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.14409968 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.13502341 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 1.13204676 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11890727 |
| 42 | Morphine addiction_Homo sapiens_hsa05032 | 1.11020569 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09609665 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09426206 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09000091 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05980922 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.05600063 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04890579 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02020113 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00314766 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00306990 |
| 52 | Nicotine addiction_Homo sapiens_hsa05033 | 0.99686713 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99678067 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99016422 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97289796 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95650587 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94072770 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.92176567 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.91836698 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89988605 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.88925090 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.88607024 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.88172308 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 0.87713871 |
| 65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86392283 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.85312680 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82924226 |
| 68 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82841967 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82429018 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.82032245 |
| 71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81872263 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80950521 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80700989 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80410255 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.79337295 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79115200 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76397559 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76093512 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73739521 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73520321 |
| 81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72888778 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.72653879 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71002433 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69432531 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68290769 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67806990 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67360078 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65375555 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62219627 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.61852187 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61113863 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59880106 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59808789 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59769353 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58388710 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57119736 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56727451 |
| 98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55892460 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55304044 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55088790 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54911424 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49903215 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47976671 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47532192 |
| 105 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46181260 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44983158 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44383463 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41047463 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40009289 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38664863 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38351048 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38251687 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36075655 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35139239 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30114950 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.27125181 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26553079 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24002996 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23223733 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22419571 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21835399 |
| 122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.18819735 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18313922 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18240403 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17556893 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.15697431 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12213432 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.07716348 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.07426734 |
| 130 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.02641623 |

